See All Slides - tctmd.com

Slides

Presentation TCT 2013

The Science and Rationale of Bioabsorbable Vascular Scaffolds in the Treatment of Coronary Artery Disease

Presenter: Gabriel Maluenda

October 29, 2013

Presentation TCT 2013

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

Presenter: Bernard Chevalier

October 29, 2013

Presentation TCT 2013

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Presenter: Yoshinobu Onuma

October 29, 2013

Presentation

Coronary Artery Disease and CTA-Based Imaging: What Does It Mean?

Presenter: James Min

October 29, 2013

Presentation TCT 2013

TCT-55. Outcomes of Transfemoral Bivalirudin are Equivalent to Transradial PCI. “Old Dogs Don't Need to Learn New Tricks”

Presenter: Sundeep Adusumalli

October 29, 2013

Presentation TCT 2013

Holographic Imaging in the Cath Lab: First in Human Experiences

Presenter: Elchanan Bruckheimer

October 29, 2013

Presentation TCT 2013

Consensus and Take-home Messages(2)

Presenter: Herv? Le Breton

October 29, 2013

Presentation TCT 2013

Left Atrial Appendage Occlusion: What Success Looks Like

Presenter: Matthew Price

October 29, 2013

Presentation TCT 2013

Return to the Two Cases: Panel Discussion on Treatment Strategies (and Case Conclusions)(3)

Presenter: Francesco Maisano

October 29, 2013

Presentation TCT 2013

TCT-17. Current Perspectives On Stent Fractures: Trends, Characteristics And Outcomes From The Food And Drug Administration Manufacturer And User Facility Device Experience...

Presenter: Al Fazir Omar

October 29, 2013

Advertisement

Slides

The Science and Rationale of Bioabsorbable Vascular Scaffolds in the Treatment of Coronary Artery Disease

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Coronary Artery Disease and CTA-Based Imaging: What Does It Mean?

TCT-55. Outcomes of Transfemoral Bivalirudin are Equivalent to Transradial PCI. “Old Dogs Don't Need to Learn New Tricks”

Holographic Imaging in the Cath Lab: First in Human Experiences

Consensus and Take-home Messages(2)

Left Atrial Appendage Occlusion: What Success Looks Like

Return to the Two Cases: Panel Discussion on Treatment Strategies (and Case Conclusions)(3)

TCT-17. Current Perspectives On Stent Fractures: Trends, Characteristics And Outcomes From The Food And Drug Administration Manufacturer And User Facility Device Experience...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content